Aptitude Awarded a BARDA Contract Modification to Add Avian Flu Detection to the Metrix® Platform

This funding will support the development of Avian H5 Influenza detection capabilities on the Metrix® platform, expanding upon its recent U.S. Food and Drug Administration (FDA) emergency use authorized COVID-19/Flu multiplex test.